Your browser doesn't support javascript.
loading
Breast cancer survival in Brazil: How much health care access impact on cancer outcomes?
Caleffi, Maira; Crivelatti, Isabel; Burchardt, Norah A; Ribeiro, Rodrigo A; Acevedo, Yulieth; Job, Laura Gianotti; Nonnemacher, Nouara; Rosa, Daniela Dornelles.
Afiliação
  • Caleffi M; Breast Cancer Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil. Electronic address: Maira.caleffi@hmv.org.br.
  • Crivelatti I; Breast Cancer Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Burchardt NA; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ribeiro RA; Post-Graduation Program in Epidemiology, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil.
  • Acevedo Y; Breast Cancer Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Job LG; Breast Cancer Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Nonnemacher N; Breast Cancer Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Rosa DD; Breast Cancer Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil; Post-Graduation Program in Pathology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil; Oncology Center, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
Breast ; 54: 155-159, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33120081
BACKGROUND: Breast cancer has a high incidence and increasing mortality in Southern Brazil. The present study evaluated clinical and sociodemographic characteristics, and their association with overall survival in a private cancer center. METHODS: 1113 breast cancer patients were included in this study. The association between survival and clinicopathological and sociodemographic characteristics was analyzed using Cox regression and Kaplan-Meyer curves. RESULTS: Median age at diagnosis was 52 years (SD 13.5). Most patients were diagnosed in stages 0 and I (62.7%), while only 1.3% had stage IV disease. Five- and 10-year overall survival were 93.5% and 83.8%, respectively. According to multivariate analysis, age at diagnosis (HR 1.05; CI95 1.03-1.06), staging (stage III: HR 4.04; CI95 1.34-12.19; stage IV: HR 9.61; CI95 2.17-42.50), high KI67 (HR 5.46; CI95 1.27-23.32) and distant recurrence (HR 7.28; CI95 4.79-11.06) were significantly associated with survival. Smoking status, years of education, BMI, and tumor biological status were not significantly associated with mortality. CONCLUSIONS: This cohort of Brazilian patients, who received timely and appropriate treatment, achieved outcomes that are comparable to those from high income countries. Breast cancer mortality seems dependent on the quality of health care available to patients.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Acessibilidade aos Serviços de Saúde Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Acessibilidade aos Serviços de Saúde Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda